Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation

Taylor F. Dowsley, David B. Bayne, Alan Norman Langnas, Ioana Dumitru, John Robert Windle, Thomas Richard Porter, Eugenia Raichlin

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

BACKGROUND: Liver transplantation (LTx) is a life-saving treatment of end-stage liver disease. Cardiac complications including heart failure (HF) are among the leading causes of death after LTx. THE AIM: The aim is to identify clinical and echocardiographic predictors of developing HF after LTx. METHODS: Patients who underwent LTx at the University of Nebraska Medical Center (UNMC) between January 2001 and January 2009 and had echocardiographic study before and within 6 months after transplantation were identified. Patients with coronary artery disease (>70% lesion) were excluded. HF after LTx was defined by clinical signs, symptoms, radiographic evidence of pulmonary congestion, and echocardiographic evidence of left ventricular dysfunction (left ventricle ejection fraction <50%). RESULTS: Among 107 patients (presented as mean age [SD], 55 [10] years; male, 70%) who met the inclusion criteria, 26 (24%) patients developed HF after LTx. The pre-LTx left ventricle ejection fraction did not differ between the HF (69 [7]) and the control groups (69 [7] vs. 67 [6], P=0.30). However, pre-LTx elevation of early mitral inflow velocity/mitral annular velocity (P=0.02), increased left atrial volume index (P=0.05), and lower mean arterial pressure (P=0.03) were predictors of HF after LTx in multivariate analysis. Early mitral inflow velocity/mitral annular velocity greater than 10 and left atrial volume index 40 mL/m2 or more were associated with a 3.4-fold (confidence interval, 1.2-9.4; P=0.017) and 2.9-fold (confidence interval, 1.1-7.5; P=0.03) increase in risk of development of HF after LTx, respectively. CONCLUSIONS: This study suggests that elevated markers of diastolic dysfunction during pre-LTx echocardiographic evaluation are associated with an excess risk of HF and may predict post-LTx survival.

Original languageEnglish (US)
Pages (from-to)646-651
Number of pages6
JournalTransplantation
Volume94
Issue number6
DOIs
StatePublished - Sep 27 2012

Fingerprint

End Stage Liver Disease
Liver Transplantation
Heart Failure
Heart Ventricles
Confidence Intervals
Left Ventricular Dysfunction
Signs and Symptoms
Coronary Artery Disease
Cause of Death
Arterial Pressure
Multivariate Analysis
Transplantation
Lung
Control Groups
Survival

Keywords

  • Cirrhotic cardiomyopathy
  • Heart failure
  • and Diastolic dysfunction

ASJC Scopus subject areas

  • Transplantation

Cite this

Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation. / Dowsley, Taylor F.; Bayne, David B.; Langnas, Alan Norman; Dumitru, Ioana; Windle, John Robert; Porter, Thomas Richard; Raichlin, Eugenia.

In: Transplantation, Vol. 94, No. 6, 27.09.2012, p. 646-651.

Research output: Contribution to journalArticle

@article{b3d22cd269494f2aa4fc3d34b8f977ba,
title = "Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation",
abstract = "BACKGROUND: Liver transplantation (LTx) is a life-saving treatment of end-stage liver disease. Cardiac complications including heart failure (HF) are among the leading causes of death after LTx. THE AIM: The aim is to identify clinical and echocardiographic predictors of developing HF after LTx. METHODS: Patients who underwent LTx at the University of Nebraska Medical Center (UNMC) between January 2001 and January 2009 and had echocardiographic study before and within 6 months after transplantation were identified. Patients with coronary artery disease (>70{\%} lesion) were excluded. HF after LTx was defined by clinical signs, symptoms, radiographic evidence of pulmonary congestion, and echocardiographic evidence of left ventricular dysfunction (left ventricle ejection fraction <50{\%}). RESULTS: Among 107 patients (presented as mean age [SD], 55 [10] years; male, 70{\%}) who met the inclusion criteria, 26 (24{\%}) patients developed HF after LTx. The pre-LTx left ventricle ejection fraction did not differ between the HF (69 [7]) and the control groups (69 [7] vs. 67 [6], P=0.30). However, pre-LTx elevation of early mitral inflow velocity/mitral annular velocity (P=0.02), increased left atrial volume index (P=0.05), and lower mean arterial pressure (P=0.03) were predictors of HF after LTx in multivariate analysis. Early mitral inflow velocity/mitral annular velocity greater than 10 and left atrial volume index 40 mL/m2 or more were associated with a 3.4-fold (confidence interval, 1.2-9.4; P=0.017) and 2.9-fold (confidence interval, 1.1-7.5; P=0.03) increase in risk of development of HF after LTx, respectively. CONCLUSIONS: This study suggests that elevated markers of diastolic dysfunction during pre-LTx echocardiographic evaluation are associated with an excess risk of HF and may predict post-LTx survival.",
keywords = "Cirrhotic cardiomyopathy, Heart failure, and Diastolic dysfunction",
author = "Dowsley, {Taylor F.} and Bayne, {David B.} and Langnas, {Alan Norman} and Ioana Dumitru and Windle, {John Robert} and Porter, {Thomas Richard} and Eugenia Raichlin",
year = "2012",
month = "9",
day = "27",
doi = "10.1097/TP.0b013e31825f0f97",
language = "English (US)",
volume = "94",
pages = "646--651",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation

AU - Dowsley, Taylor F.

AU - Bayne, David B.

AU - Langnas, Alan Norman

AU - Dumitru, Ioana

AU - Windle, John Robert

AU - Porter, Thomas Richard

AU - Raichlin, Eugenia

PY - 2012/9/27

Y1 - 2012/9/27

N2 - BACKGROUND: Liver transplantation (LTx) is a life-saving treatment of end-stage liver disease. Cardiac complications including heart failure (HF) are among the leading causes of death after LTx. THE AIM: The aim is to identify clinical and echocardiographic predictors of developing HF after LTx. METHODS: Patients who underwent LTx at the University of Nebraska Medical Center (UNMC) between January 2001 and January 2009 and had echocardiographic study before and within 6 months after transplantation were identified. Patients with coronary artery disease (>70% lesion) were excluded. HF after LTx was defined by clinical signs, symptoms, radiographic evidence of pulmonary congestion, and echocardiographic evidence of left ventricular dysfunction (left ventricle ejection fraction <50%). RESULTS: Among 107 patients (presented as mean age [SD], 55 [10] years; male, 70%) who met the inclusion criteria, 26 (24%) patients developed HF after LTx. The pre-LTx left ventricle ejection fraction did not differ between the HF (69 [7]) and the control groups (69 [7] vs. 67 [6], P=0.30). However, pre-LTx elevation of early mitral inflow velocity/mitral annular velocity (P=0.02), increased left atrial volume index (P=0.05), and lower mean arterial pressure (P=0.03) were predictors of HF after LTx in multivariate analysis. Early mitral inflow velocity/mitral annular velocity greater than 10 and left atrial volume index 40 mL/m2 or more were associated with a 3.4-fold (confidence interval, 1.2-9.4; P=0.017) and 2.9-fold (confidence interval, 1.1-7.5; P=0.03) increase in risk of development of HF after LTx, respectively. CONCLUSIONS: This study suggests that elevated markers of diastolic dysfunction during pre-LTx echocardiographic evaluation are associated with an excess risk of HF and may predict post-LTx survival.

AB - BACKGROUND: Liver transplantation (LTx) is a life-saving treatment of end-stage liver disease. Cardiac complications including heart failure (HF) are among the leading causes of death after LTx. THE AIM: The aim is to identify clinical and echocardiographic predictors of developing HF after LTx. METHODS: Patients who underwent LTx at the University of Nebraska Medical Center (UNMC) between January 2001 and January 2009 and had echocardiographic study before and within 6 months after transplantation were identified. Patients with coronary artery disease (>70% lesion) were excluded. HF after LTx was defined by clinical signs, symptoms, radiographic evidence of pulmonary congestion, and echocardiographic evidence of left ventricular dysfunction (left ventricle ejection fraction <50%). RESULTS: Among 107 patients (presented as mean age [SD], 55 [10] years; male, 70%) who met the inclusion criteria, 26 (24%) patients developed HF after LTx. The pre-LTx left ventricle ejection fraction did not differ between the HF (69 [7]) and the control groups (69 [7] vs. 67 [6], P=0.30). However, pre-LTx elevation of early mitral inflow velocity/mitral annular velocity (P=0.02), increased left atrial volume index (P=0.05), and lower mean arterial pressure (P=0.03) were predictors of HF after LTx in multivariate analysis. Early mitral inflow velocity/mitral annular velocity greater than 10 and left atrial volume index 40 mL/m2 or more were associated with a 3.4-fold (confidence interval, 1.2-9.4; P=0.017) and 2.9-fold (confidence interval, 1.1-7.5; P=0.03) increase in risk of development of HF after LTx, respectively. CONCLUSIONS: This study suggests that elevated markers of diastolic dysfunction during pre-LTx echocardiographic evaluation are associated with an excess risk of HF and may predict post-LTx survival.

KW - Cirrhotic cardiomyopathy

KW - Heart failure

KW - and Diastolic dysfunction

UR - http://www.scopus.com/inward/record.url?scp=84866731415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866731415&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31825f0f97

DO - 10.1097/TP.0b013e31825f0f97

M3 - Article

VL - 94

SP - 646

EP - 651

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -